COLITE MICROSCOPICA: LA COLECISTECTOMIA AUMENTA DI DUE VOLTE IL RISCHIO ! UN GRANDE STUDIO OSSERVAZIONALE SVEDESE SU 13.000 PAZIENTI. DA “Clin Gastroenterol Hepatol ” (FREE)

Cholecystectomy Is a Risk Factor for Microscopic Colitis: A Nationwide Population-based Matched Case Control Study David Bergman et al. Abstract Background & aims: Studies have linked bile acid malabsorption and microscopic colitis (MC), with some patients with MC responding to treatment with bile acid sequestrants. However, the literature on cholecystectomy as a risk factor for MC…

ABLAZIONE DELLE CISTI PANCREATICHE: O ECOENDOSCOPISTI E PANCREATOLOGI CHE NE PENSATE? UNA REVIEW DA “ENDOSCOPIC ULTRASOUND” (FREE)

EUS-guided ablation for pancreatic cystic lesions: An updated review Jiang, Mengruo et al. ABSTRACT Pancreatic cystic lesions (PCLs) are a globally prevalent condition, with incidence increasing with age. The proper treatment modality for PCLs remains a controversial topic. EUS-guided ablation represents an innovative and promising minimally invasive treatment for selected PCL patients, including EUS-guided pancreatic…

PORFIRIE: UNA MAGNIFICA REVIEW DAL CENTRO DI MODENA! ATTENZIONE O EPATOLOGI. LE ABBIAMO UN PO’ TRASCURATE. DA “HEPATOLOGY COMMUNICATIONS” (FREE)

Porphyrias: Pathophysiology and clinical management recommendations for hepatologists Ricci, Andrea et al. per il  Porphyria Working Group Abstract In humans, an enzyme dysfunction in heme biosynthesis results in a heterogenous group of diseases collectively known as porphyrias. From a clinical standpoint, porphyrias can be classified as erythropoietic (congenital erythropoietic porphyria—CEP, erythropoietic/X-linked protoporphyria—EPP/XLP) or hepatic (acute…

CANCRO DEL COLON CON METASTASI: LE ULTIME EVIDENZE SUL TRATTAMENTO SISTEMICO. DA “GUT” (FREE)

Current and emerging concepts for systemic treatment of metastatic colorectal cancer Christoph Steup et al. Abstract Colorectal cancer (CRC) is one of the most common malignant cancers and its incidence is steadily rising particularly in young patients. While screening measures and the widespread availability of surgical treatment have led to an impressive improvement of prognosis…

MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE) : UNA MAGNIFICA REVIEW DA “JAMA” (FREE). GRANDE SALVATORE PETTA!

Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults. A Review Herbert Tilg, MD; Salvatore Petta, MD et al. Abstract Importance  Metabolic dysfunction–associated steatotic liver disease (MASLD) includes a range of liver conditions, progressing from isolated steatosis (characterized by fat accumulation in the liver without inflammation) to metabolic dysfunction–associated steatohepatitis (MASH), which involves fat accumulation and inflammation in the…

COLANGITE BILIARE PRIMITIVA : UNA RAPIDA REVIEW DA 5 MINUTI! DA”JAMA” (FREE)

Primary Biliary Cholangitis Michele M. Tana, MD, MHS1; Gideon M. Hirschfield, MA, MBBChir, PhD2 Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease that causes small bile duct destruction, impaired bile flow, and biliary fibrosis. Increased liver fibrosis severity is associated with worse survival and, if untreated, 40% of patients develop cirrhosis within 10 years of diagnosis.1 PBC typically affects females (90%)…